Publications by authors named "Erin Funk"
Purpose: The financial burden experienced by blood or marrow transplant (BMT) survivors during the COVID-19 pandemic remains unstudied. We evaluated the risk for high out-of-pocket medical costs and associated financial burden experienced by BMT survivors and a sibling comparison group during the COVID-19 pandemic.
Methods: This study included 2,370 BMT survivors and 750 siblings who completed the BMT Survivor Study survey during the pandemic.
Article Synopsis
- Living in disadvantaged neighborhoods negatively impacts the health of Blood or Marrow Transplant (BMT) survivors, leading to increased chronic health issues and less routine healthcare utilization.
- A study of 2,857 BMT survivors found those in more deprived areas reported longer gaps since their last check-up and worse self-reported health.
- The data suggests that improving healthcare access and support for patients in these neighborhoods could enhance their long-term health outcomes and care.
Article Synopsis
- Researchers examined trends in life expectancy and late mortality causes among patients who had autologous blood or marrow transplants (BMT) over 30 years using a survivor study.
- The study included 4,702 patients, primarily non-Hispanic White males, and found a 7-year reduction in life expectancy while showing improved survival rates over time, especially for those treated for Hodgkin lymphoma.
- Although late mortality rates decreased, challenges remain in addressing infections, new cancers, and heart or kidney diseases among these patients.
Survival after blood or marrow transplantation (BMT) for inborn errors of metabolism (IEM) is excellent; however, the burden of morbidity in long-term survivors of BMT for IEM remains understudied. This study examined the risk of chronic health conditions (CHC) in ≥2-year survivors of allogeneic BMT for IEM performed between 1974 and 2014 using the BMT Survivor Study. In this retrospective cohort study, participants (or their parents; n = 154) reported demographic data and CHCs (graded using Common Terminology Criteria for Adverse Events version 5), and transplantation characteristics were obtained from institutional databases.
View Article and Find Full Text PDFImportance: The past 4 decades have seen substantial changes in allogeneic blood or marrow transplantation (BMT) practice, with the overarching goal of expanding the eligible patient pool while optimizing disease-free survival.
Objective: To determine trends in life expectancy and cause-specific late mortality after allogeneic BMT performed over a 40-year period.
Design, Setting, And Participants: A retrospective cohort study of 4741 individuals who lived 2 or more years after allogeneic BMT performed between January 1, 1974, and December 31, 2014, was conducted at City of Hope, University of Minnesota, or University of Alabama at Birmingham.